dihydroxyphenylalanine has been researched along with Remission, Spontaneous in 8 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jönsson, PE | 1 |
| Agrup, G | 1 |
| Arnbjörnsson, E | 1 |
| Hafström, L | 1 |
| Rorsman, H | 1 |
| Spivak, B | 1 |
| Maline, DI | 1 |
| Vered, Y | 1 |
| Kozyrev, VN | 1 |
| Mester, R | 1 |
| Neduva, SA | 1 |
| Ravilov, RS | 1 |
| Graff, E | 1 |
| Weizman, A | 1 |
| Papaioannou, AN | 1 |
| Maskin, MB | 1 |
| Riklan, M | 1 |
| Chabot, D | 1 |
| Náhunek, K | 1 |
| Svestka, J | 1 |
| Kamenická, V | 1 |
| Rodová, A | 1 |
| Rosati, G | 1 |
| Agnetti, V | 1 |
| Mura, F | 1 |
| Granieri, E | 1 |
| Boshes, B | 1 |
| Persson, T | 1 |
| Wålinder, J | 1 |
2 trials available for dihydroxyphenylalanine and Remission, Spontaneous
| Article | Year |
|---|---|
Preliminary clinical experience with L-dopa in endogenous depressions.
Topics: Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; H | 1972 |
[Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
Topics: Arteriosclerosis; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Evaluation; Female; Humans; | 1974 |
6 other studies available for dihydroxyphenylalanine and Remission, Spontaneous
| Article | Year |
|---|---|
Treatment of malignant melanoma with dacarbazin (DTIC-DOME) with special reference to urinary excretion of 5-S-cysteinyldopa.
Topics: Adult; Aged; Brain Neoplasms; Cysteinyldopa; Dacarbazine; Digestive System; Dihydroxyphenylalanine; | 1980 |
Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome.
Topics: Acute Disease; Adult; Catecholamines; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; | 2000 |
Prolactin, levodopa, and immune response in breast cancer.
Topics: Antibody Formation; Breast; Breast Neoplasms; Carcinoma; Dihydroxyphenylalanine; Female; Humans; Lym | 1972 |
Emotional functions in short-term vs. long-term L-Dopa therapy in Parkinsonism.
Topics: Depression; Dihydroxyphenylalanine; Emotions; Female; Humans; Male; Middle Aged; MMPI; Parkinson Dis | 1973 |
Long-term treatment of parkinsonism with levodopa.
Topics: Basal Ganglia; Dihydroxyphenylalanine; Humans; Intelligence; Long-Term Care; Melanins; Memory; Parki | 1971 |
L-DOPA in the treatment of depressive symptoms.
Topics: Adult; Depression; Dihydroxyphenylalanine; Female; Humans; Male; Mental Disorders; Middle Aged; Remi | 1971 |